Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Sexual health and fertility for individuals with inflammatory bowel disease.

Leenhardt R, Rivière P, Papazian P, Nion-Larmurier I, Girard G, Laharie D, Marteau P.

World J Gastroenterol. 2019 Sep 28;25(36):5423-5433. doi: 10.3748/wjg.v25.i36.5423. Review.

2.

Concise Commentary: Second Line Is Not Second Best-Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis.

Rivière P, Laharie D, Marteau P.

Dig Dis Sci. 2019 Sep 5. doi: 10.1007/s10620-019-05788-z. [Epub ahead of print] No abstract available.

PMID:
31489565
3.

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Bouguen G, Abitbol V, Fumery M, Gagniere C, Bouhnik Y; OBSERV-IBD study group, the GETAID.

Aliment Pharmacol Ther. 2019 Jul;50(1):40-53. doi: 10.1111/apt.15294. Epub 2019 Jun 5.

PMID:
31165509
4.

Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study.

Geffrier C, de Parades V, Abramowitz L, Benfredj P, Bonnaud G, Bord C, Bouchard D, Bouguen G, Devulder F, Didelot JM, Fathallah N, Higuero T, Lesage X, Nouts A, Petit P, Pigot F, Pommaret E, Roumeguere P, Siproudhis L, Staumont G, Zeitoun JD, Marteau P.

Clin Res Hepatol Gastroenterol. 2019 Aug;43(4):483-496. doi: 10.1016/j.clinre.2018.12.003. Epub 2019 Mar 29.

PMID:
30935906
5.

[Anoperineal lesions in Crohn's disease: Still frequent despite anti-TNF agents].

Severyns T, Fathallah N, Beaussier H, Marteau P, de Parades V.

Presse Med. 2019 Apr;48(4):460-461. doi: 10.1016/j.lpm.2019.02.015. Epub 2019 Mar 27. French. No abstract available.

PMID:
30926212
6.

Nomenclature and semantic description of vascular lesions in small bowel capsule endoscopy: an international Delphi consensus statement.

Leenhardt R, Li C, Koulaouzidis A, Cavallaro F, Cholet F, Eliakim R, Fernandez-Urien I, Kopylov U, McAlindon M, Németh A, Plevris JN, Rahmi G, Rondonotti E, Saurin JC, Tontini GE, Toth E, Yung D, Marteau P, Dray X.

Endosc Int Open. 2019 Mar;7(3):E372-E379. doi: 10.1055/a-0761-9742. Epub 2019 Feb 28.

7.

Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonography.

Marteau P, Cornec D, Gouillou M, Jousse-Joulin S, Guellec D, Costa S, Marhadour T, Carvajal Alegria G, Varache S, Gauvin Y, Boisramé S, Le Pottier L, Renaudineau Y, Pers JO, Saraux A, Devauchelle-Pensec V.

Joint Bone Spine. 2019 Oct;86(5):627-632. doi: 10.1016/j.jbspin.2019.01.025. Epub 2019 Feb 11.

PMID:
30763687
8.
9.

Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE).

Högenauer C, Mahida Y, Stallmach A, Marteau P, Rydzewska G, Ivashkin V, Gargalianos-Kakolyris P, Michon I, Adomakoh N, Georgopali A, Tretter R, Karas A, Reinisch W.

J Antimicrob Chemother. 2018 Dec 1;73(12):3430-3441. doi: 10.1093/jac/dky368.

PMID:
30260412
10.

Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota.

Landman C, Grill JP, Mallet JM, Marteau P, Humbert L, Le Balc'h E, Maubert MA, Perez K, Chaara W, Brot L, Beaugerie L, Sokol H, Thenet S, Rainteau D, Seksik P, Quévrain E; Saint Antoine IBD Network.

PLoS One. 2018 Aug 29;13(8):e0202587. doi: 10.1371/journal.pone.0202587. eCollection 2018.

11.

Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study.

Auzolle C, Nancey S, Tran-Minh ML, Buisson A, Pariente B, Stefanescu C, Fumery M, Marteau P, Treton X, Hammoudi N; REMIND Study Group Investigators, Jouven X, Seksik P, Allez M.

Aliment Pharmacol Ther. 2018 Nov;48(9):924-932. doi: 10.1111/apt.14944. Epub 2018 Aug 20.

PMID:
30126030
12.

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Gagnière C, Bourrier A, Seksik P, Gornet JM, DeWit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Buisson A, Pariente B, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Cosnes J, Amiot A; GETAID INFOPRO study group.

Aliment Pharmacol Ther. 2018 Oct;48(7):713-722. doi: 10.1111/apt.14926. Epub 2018 Aug 2.

PMID:
30069921
13.

A neural network algorithm for detection of GI angiectasia during small-bowel capsule endoscopy.

Leenhardt R, Vasseur P, Li C, Saurin JC, Rahmi G, Cholet F, Becq A, Marteau P, Histace A, Dray X; CAD-CAP Database Working Group.

Gastrointest Endosc. 2019 Jan;89(1):189-194. doi: 10.1016/j.gie.2018.06.036. Epub 2018 Jul 11.

PMID:
30017868
14.

Development of a computed cleansing score to assess quality of bowel preparation in colon capsule endoscopy.

Becq A, Histace A, Camus M, Nion-Larmurier I, Abou Ali E, Pietri O, Romain O, Chaput U, Li C, Marteau P, Florent C, Dray X.

Endosc Int Open. 2018 Jul;6(7):E844-E850. doi: 10.1055/a-0577-2897. Epub 2018 Jul 4.

15.

Development and validation of a computed assessment of cleansing score for evaluation of quality of small-bowel visualization in capsule endoscopy.

Abou Ali E, Histace A, Camus M, Gerometta R, Becq A, Pietri O, Nion-Larmurier I, Li C, Chaput U, Marteau P, Florent C, Dray X.

Endosc Int Open. 2018 Jun;6(6):E646-E651. doi: 10.1055/a-0581-8758. Epub 2018 May 25.

16.

[Probiotics: Don't through baby with the bath water].

Marteau P.

Presse Med. 2018 May;47(5):417-418. doi: 10.1016/j.lpm.2018.03.021. Epub 2018 Apr 24. French. No abstract available.

PMID:
29703572
17.

Development and validation of an automated algorithm to evaluate the abundance of bubbles in small bowel capsule endoscopy.

Pietri O, Rezgui G, Histace A, Camus M, Nion-Larmurier I, Li C, Becq A, Ali EA, Romain O, Chaput U, Marteau P, Florent C, Dray X.

Endosc Int Open. 2018 Apr;6(4):E462-E469. doi: 10.1055/a-0573-1044. Epub 2018 Mar 29.

18.

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology.

Marteau P, Adamsbaum C, Rossi-Semerano L, De Bandt M, Lemelle I, Deslandre C, Tran TA, Lohse A, Solau-Gervais E, Sordet C, Pillet P, Bader-Meunier B, Wipff J, Gaujoux-Viala C, Breton S, Devauchelle-Pensec V.

Eur Radiol. 2018 Sep;28(9):3963-3976. doi: 10.1007/s00330-018-5304-7. Epub 2018 Mar 26. Review.

19.

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A; GETAID OBSERV-IBD study group.

Aliment Pharmacol Ther. 2018 Feb;47(4):485-493. doi: 10.1111/apt.14419. Epub 2017 Dec 18.

20.

Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission.

Reenaers C, Mary JY, Nachury M, Bouhnik Y, Laharie D, Allez M, Fumery M, Amiot A, Savoye G, Altwegg R, Devos M, Malamut G, Bourreille A, Flourie B, Marteau P, Vuitton L, Coffin B, Viennot S, Lambert J, Colombel JF, Louis E; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):234-243.e2. doi: 10.1016/j.cgh.2017.09.061. Epub 2017 Oct 7.

21.

Targeted temperature management using the "Esophageal Cooling Device" after cardiac arrest (the COOL study): A feasibility and safety study.

Goury A, Poirson F, Chaput U, Voicu S, Garçon P, Beeken T, Malissin I, Kerdjana L, Chelly J, Vodovar D, Oueslati H, Ekherian JM, Marteau P, Vicaut E, Megarbane B, Deye N.

Resuscitation. 2017 Dec;121:54-61. doi: 10.1016/j.resuscitation.2017.09.021. Epub 2017 Sep 23.

22.

Elaboration and validation of Crohn's disease anoperineal lesions consensual definitions.

Horaist C, de Parades V, Abramowitz L, Benfredj P, Bonnaud G, Bouchard D, Fathallah N, Sénéjoux A, Siproudhis L, Staumont G, Viguier M, Marteau P.

World J Gastroenterol. 2017 Aug 7;23(29):5371-5378. doi: 10.3748/wjg.v23.i29.5371.

23.

Gut microbial profile in primary biliary cholangitis: Towards bioindicators.

Lemoinne S, Marteau P.

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):507-508. doi: 10.1016/j.clinre.2017.06.002. Epub 2017 Aug 7. No abstract available.

PMID:
28797907
24.

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases.

Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, Bournet B, Marteau P, Amiot A, Laharie D, Trang C, Coffin B, Bellaiche G, Cadiot G, Reenaers C, Racine A, Viennot S, Pauwels A, Bouguen G, Savoye G, Pelletier AL, Pineton de Chambrun G, Lahmek P, Nahon S, Abitbol V; GETAID-AIP study group.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):59-67. doi: 10.1016/j.cgh.2017.07.033. Epub 2017 Aug 4.

PMID:
28782667
25.

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Gagniere C, Bouhnik Y; OBSERV-IBD study group and the GETAID.

Aliment Pharmacol Ther. 2017 Aug;46(3):310-321. doi: 10.1111/apt.14167. Epub 2017 Jun 8.

26.

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F, Seksik P, Simon M, Fléjou JF, Colombel JF, Charlois AL, Roblin X, Nancey S, Bouhnik Y, Berger F, Flourié B; the GETAID.

Gut. 2018 Apr;67(4):616-624. doi: 10.1136/gutjnl-2016-311892. Epub 2017 Jan 23.

PMID:
28115492
27.

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

Vuitton L, Peyrin-Biroulet L, Colombel JF, Pariente B, Pineton de Chambrun G, Walsh AJ, Panes J, Travis SP, Mary JY, Marteau P.

Aliment Pharmacol Ther. 2017 Mar;45(6):801-813. doi: 10.1111/apt.13948. Epub 2017 Jan 23. Review.

28.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4.

29.

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, Jouven X, Treton X, Allez M; REMIND study group investigators.

Am J Gastroenterol. 2017 Feb;112(2):337-345. doi: 10.1038/ajg.2016.541. Epub 2016 Dec 13.

PMID:
27958285
30.

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourié B; GETAID.

Inflamm Bowel Dis. 2016 Dec;22(12):2924-2932.

31.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

PMID:
26917043
32.

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

Cosnes J, Sokol H, Bourrier A, Nion-Larmurier I, Wisniewski A, Landman C, Marteau P, Beaugerie L, Perez K, Seksik P.

Aliment Pharmacol Ther. 2016 Nov;44(10):1102-1113. doi: 10.1111/apt.13808. Epub 2016 Sep 26.

33.

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.

Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A, Bommelaer G, Dib N, Bigard MA, Viennot S, Hébuterne X, Gornet JM, Marteau P, Bouhnik Y, Abitbol V, Nahon S; GETAID.

J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11.

PMID:
27402916
34.

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease.

Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, Cadiot G, Bourreille A, Carbonnel F, Bouhnik Y, Coffin B, Duclos B, Dupas JL, Moreau J, Louis E, Mary JY; GETAID.

J Crohns Colitis. 2016 Sep;10(9):1001-5. doi: 10.1093/ecco-jcc/jjw082. Epub 2016 Apr 11.

35.

Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study.

Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, Jüsten P, Marteau P, Urdaci MC.

Immun Ageing. 2015 Dec 3;12:24. doi: 10.1186/s12979-015-0051-y. eCollection 2015.

36.

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.

Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P; GETAID.

Gut. 2016 Jun;65(6):954-62. doi: 10.1136/gutjnl-2015-309184. Epub 2015 Dec 1.

37.

Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease.

Simon M, Pariente B, Lambert J, Cosnes J, Bouhnik Y, Marteau P, Allez M, Colombel JF, Gornet JM.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):966-972.e2. doi: 10.1016/j.cgh.2015.10.034. Epub 2015 Nov 18.

PMID:
26598226
38.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

39.

Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons.

Bejaoui M, Sokol H, Marteau P.

Dig Dis. 2015;33 Suppl 1:105-112. Epub 2015 Sep 14.

PMID:
26366577
40.

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.

Vuitton L, Marteau P, Sandborn WJ, Levesque BG, Feagan B, Vermeire S, Danese S, D'Haens G, Lowenberg M, Khanna R, Fiorino G, Travis S, Mary JY, Peyrin-Biroulet L.

Gut. 2016 Sep;65(9):1447-55. doi: 10.1136/gutjnl-2015-309903. Epub 2015 Sep 9.

PMID:
26353983
41.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF.

Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25. Review.

PMID:
26303131
42.

Emerging indications of endoscopic radiofrequency ablation.

Becq A, Camus M, Rahmi G, de Parades V, Marteau P, Dray X.

United European Gastroenterol J. 2015 Aug;3(4):313-24. doi: 10.1177/2050640615571159. Review.

43.

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

Travis SP, Schnell D, Feagan BG, Abreu MT, Altman DG, Hanauer SB, Krzeski P, Lichtenstein GR, Marteau PR, Mary JY, Reinisch W, Sands BE, Schnell P, Yacyshyn BR, Colombel JF, Bernhardt CA, Sandborn WJ.

J Crohns Colitis. 2015 Aug;9(8):607-16. doi: 10.1093/ecco-jcc/jjv077. Epub 2015 May 8.

44.

Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features.

Dohan A, Faraoun SA, Barral M, Guerrache Y, Boudiaf M, Dray X, Hoeffel C, Allez M, Farges O, Beaugerie L, Aparicio T, Marteau P, Fishman EK, Lucidarme O, Eveno C, Pocard M, Dautry R, Soyer P.

Diagn Interv Imaging. 2015 Sep;96(9):871-83. doi: 10.1016/j.diii.2015.02.009. Epub 2015 Apr 3. Review.

45.

Digestive Diseases. Introduction.

Dignass A, Allez M, Danese S, Marteau P.

Dig Dis. 2014;32 Suppl 1:1. doi: 10.1159/000367977. Epub 2014 Dec 17. No abstract available.

PMID:
25531346
46.

Bleeding from gastroduodenal metastases as the first manifestation of lung adenocarcinoma.

Bouzbib C, Chaput U, Jarrin I, Lavergne-Slove A, Marteau P, Dray X.

Endoscopy. 2014;46 Suppl 1 UCTN:E474-5. doi: 10.1055/s-0034-1377540. Epub 2014 Oct 14. No abstract available.

PMID:
25314204
47.

European evidence based consensus on surgery for ulcerative colitis.

Øresland T, Bemelman WA, Sampietro GM, Spinelli A, Windsor A, Ferrante M, Marteau P, Zmora O, Kotze PG, Espin-Basany E, Tiret E, Sica G, Panis Y, Faerden AE, Biancone L, Angriman I, Serclova Z, de Buck van Overstraeten A, Gionchetti P, Stassen L, Warusavitarne J, Adamina M, Dignass A, Eliakim R, Magro F, D'Hoore A; European Crohn's and Colitis Organisation (ECCO).

J Crohns Colitis. 2015 Jan;9(1):4-25. doi: 10.1016/j.crohns.2014.08.012. No abstract available.

48.

Radiofrequency ablation for the treatment of radiation proctitis.

Dray X, Battaglia G, Wengrower D, Gonzalez P, Carlino A, Camus M, Adar T, Pérez-Roldán F, Marteau P, Repici A.

Endoscopy. 2014 Nov;46(11):970-6. doi: 10.1055/s-0034-1377756. Epub 2014 Oct 7.

PMID:
25290097
49.

Radiofrequency ablation for the treatment of gastric antral vascular ectasia.

Dray X, Repici A, Gonzalez P, Fristrup C, Lecleire S, Kantsevoy S, Wengrower D, Elbe P, Camus M, Carlino A, Pérez-Roldán F, Adar T, Marteau P.

Endoscopy. 2014 Nov;46(11):963-9. doi: 10.1055/s-0034-1377695. Epub 2014 Aug 11.

PMID:
25111135
50.

Diagnostic impact of routine colonoscopy following acute diverticulitis: A multicenter study in 808 patients and controls.

Lecleire S, Nahon S, Alatawi A, Antonietti M, Chaput U, Di-Fiore A, Alhameedi R, Marteau P, Ducrotté P, Dray X.

United European Gastroenterol J. 2014 Aug;2(4):301-6. doi: 10.1177/2050640614541765.

Supplemental Content

Loading ...
Support Center